NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Eli Lilly and Company
University Hospital, Lille
Revolution Medicines, Inc.
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Stanford University
The Cleveland Clinic
Revolution Medicines, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
University of Wisconsin, Madison
Revolution Medicines, Inc.
Assistance Publique - Hôpitaux de Paris
Syndax Pharmaceuticals
Syndax Pharmaceuticals
University Hospital, Lille
Cliniques universitaires Saint-Luc- Université Catholique de Louvain